Khaled Tolba

Assistant Professor

  • 490 Citations
  • 11 h-Index
19992018
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Khaled Tolba is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 6 Similar Profiles
docetaxel Medicine & Life Sciences
Simplexvirus Medicine & Life Sciences
Carboplatin Medicine & Life Sciences
T-Lymphocytes Medicine & Life Sciences
B-Cell Chronic Lymphocytic Leukemia Medicine & Life Sciences
Viruses Chemical Compounds
Neoplasms Medicine & Life Sciences
Non-Small Cell Lung Carcinoma Medicine & Life Sciences

Research Output 1999 2018

  • 490 Citations
  • 11 h-Index
  • 18 Article
  • 1 Comment/debate

Competing immune biomarkers in the selection of first-line therapy in non-small cell lung cancer

Tolba, K., Jan 1 2018, In : European Oncology and Haematology. 14, 2, p. 67-69 3 p.

Research output: Contribution to journalComment/debate

Non-Small Cell Lung Carcinoma
Biomarkers
Therapeutics
pembrolizumab
14 Citations (Scopus)

Durable Response to Afatinib in Lung Adenocarcinoma Harboring NRG1 Gene Fusions

Gay, N. D., Wang, Y., Beadling, C., Warrick, A., Neff, T., Corless, C. & Tolba, K., Feb 25 2017, (Accepted/In press) In : Journal of Thoracic Oncology.

Research output: Contribution to journalArticle

6 Citations (Scopus)

Concurrent radiotherapy with carboplatin and cetuximab for the treatment of medically compromised patients with locoregionally advanced head and neck squamous cell carcinoma

Saigal, K., Santos, E. S., Tolba, K., Kwon, D., Elsayyad, N., Abramowitz, M. C., Mandalia, A. & Samuels, M. A., 2014, In : Frontiers in Oncology. 4 JUN, 165.

Research output: Contribution to journalArticle

Carboplatin
Radiotherapy
Therapeutics
Carcinoma, squamous cell of head and neck
Cetuximab
25 Citations (Scopus)

Induction cetuximab, paclitaxel, and carboplatin followed by chemoradiation with cetuximab, paclitaxel, and carboplatin for stage III/IV head and neck squamous cancer: a phase II ECOG-ACRIN trial (E2303)

Wanebo, H. J., Lee, J., Burtness, B. A., Ridge, J. A., Ghebremichael, M., Spencer, S. A., Psyrri, D., Pectasides, E., Rimm, D., Rosen, F. R., Hancock, M. R., Tolba, K. & Forastiere, A. A., Oct 1 2014, In : Annals of Oncology. 25, 10, p. 2036-2041 6 p.

Research output: Contribution to journalArticle

Carboplatin
Head and Neck Neoplasms
Paclitaxel
Biopsy
Survival
153 Citations (Scopus)

A phase i dose-escalation trial of 2-deoxy-d-glucose alone or combined with docetaxel in patients with advanced solid tumors

Raez, L. E., Papadopoulos, K., Ricart, A. D., Chiorean, E. G., Dipaola, R. S., Stein, M. N., Rocha Lima, C. M., Schlesselman, J. J., Tolba, K., Langmuir, V. K., Kroll, S., Jung, D. T., Kurtoglu, M., Rosenblatt, J. & Lampidis, T. J., Feb 2013, In : Cancer Chemotherapy and Pharmacology. 71, 2, p. 523-530 8 p.

Research output: Contribution to journalArticle

docetaxel
Tumors
Glucose
Neoplasms
Pharmacokinetics